Australia’s PBS, Trade Tensions & Pharmaceutical Policy | Paul Cross

Australia’s Pharmaceutical Benefits Scheme (PBS) is a world-leading model for affordable access to medicines. But new tensions—including trade concerns with the United States—have sparked debate about how public health priorities are weighed against the commercial interests of global pharmaceutical companies.In this episode of Health in Focus, Paul Cross, founder of Daily Dispatch and a leading voice in pharmaceutical policy, joins us to unpack the real story behind the headlines. We discuss the risk of foreign influence in PBS reform, the role of industry in shaping policy, and how Australia can protect its sovereignty while improving transparency in pharmaceutical decision-making.SUBSCRIBE TO THE PODCAST:🎧 Watch the Health in Focus podcast on SpotifySTAY CONNECTED:🤝 LinkedIn: https://linkedin.com/company/amplieo📺 YouTube: https://youtube.com/@amplieo📸 Instagram: www.instagram.com/amplieo Get full access to Amplieo at amplieo.substack.com/subscribe